 NESS ZIONA, Israel--BUSINESS WIRE--BiomX Inc. NYSE American: PHGE, a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer, will participate in the following upcoming investor conferences. Event: H.C. Wainwright BioConnect Conference Dates: January 11-14, 2021 Time: Playback available 6 a.m. EST January 11 Webcast link: BiomX - HCW BioConnect Conference Playback The webc 